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Abstract
A family of bioreducible poly(disulfide amine)s, which differ in the length of polymethylene spacer
[–(CH2)n–] in the main chain and the side chain, has been synthesized. These bioreducible poly
(disulfide amine)s exhibit local environment specific degradability and are associated with lower
cytotoxicity than branched poly(ethylenimine) (bPEI, 25kDa). These cationic polymers also show
higher buffering capacity and protonation degree than bPEI, facilitating the endosomal escape of
carried genetic materials. The transfection efficiency of these agents is polymethylene length
dependent. Poly(cystaminebisacrylamide-spermine) [poly(CBA-SP);], poly
(cystaminebisacrylamide-bis(3-aminopropyl)-1,3-propanediamine) [poly(CBA-APPD);], and poly
(cyxtaminebisacrylamide-bis(3-aminopropyl)-ethylenediamine) [ploy(CBA-APED);] with longer
propylene [–(CH2)3–] side spacer, demonstrate higher transfection efficacy than the counterpart poly
(cystaminebisacrylamide-bis(2-aminoethyl)-1,3-propanediamine) [poly(CBA-AEPD);] and poly
(cystaminebisacrylamide-triethylenetetramine) [poly(CBA-TETA);], which have shorter ethylene [–
(CH2)2–] side spacer. The poly(CBA-SP), poly(CBA-APPD), poly(CBA-APED) with the main
chain spacer of –(CH2)4–, –(CH2)3–, –(CH2)2– demonstrate similar transfection efficiency,
indicating the length of polymer main chain spacer has less influence on transfection efficiency.
However, with the same short ethylene [–(CH2)2–] side spacer, poly(CBA-AEPD), with the longer
main chain oligomethylene units [–(CH2)3–], showed relatively higher transfection efficiency than
poly(CBA-TETA), having shorter main chain oligomethylene units [–(CH2)2–]. Of these polymeric
carriers, poly(CBA-SP) demonstrated the highest transfection in the C2C12 cell line, while poly
(CBA-APED) showed the highest transfection in the Hela cell line. All of these agents showed greater
transfection activity than commercialized bPEI 25kDa. The poly(disulfide amine)s are promising
safe and efficient non-viral vectors for gene delivery.
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1. Introduction
The development of safe and efficient vectors is a major challenge in the development of gene
therapy to treat human diseases[1,2]. Gene delivery vectors are classified into viral and non-
viral vectors, whose advantages and disadvantages have been well documented[3,4]. Cationic
polymers are one of the main categories of non-viral vectors, having received greater attention
recently because of their inherent advantages, including non-immunogenicity, stability,
capacity to carry large nucleic acid loads, and ease of manufacturing[5,6]. By condensing
nucleic acids into nanoparitcles through electrostatic interactions, polymeric carriers can
protect nucleic acids from nuclease degradation, facilitate cellular uptake of polymer/DNA
complexes (polyplexes) via endocytosis, and induce efficient gene expression[5,7]. Over the
last two decades, many cationic polymers have been synthesized for gene delivery, such as
poly(ethylenimine) (PEI), poly(L-lysine) (PLL) and polyamidoamine dendrimers[8,9]. The
main drawback for these cationic polymers, however, is their high level of cytotoxicity, mostly
due to their non-degradability and accumulation[10]. Therefore, the design of new vectors to
overcome the problem of cytotoxicity and increase the efficiency of gene transfection has
become mandatory to advance the development of clinically efficacious gene therapy.
To successfully deliver DNA into nucleus, polymeric vectors must have multiple functional
groups to overcome a series of extra- and intracellular barriers. The first barrier is that polymers
need to condense DNA and form stable and positively-charged polyplexes[1,9,10]. Previously,
poly(amido amine)s (PAAs) with protonated amines bind DNA more strongly than their
counterpart polymers lacking protonated amine groups[11]. The modification of poly(β-amino
ester)s end groups from alcohol to primary amine groups also increases the polymers' DNA
binding affinity[12,13]. Protonatable primary amine groups in the pendant side chains allow
for strong DNA binding ability and charge density and therefore the ability to condense DNA
into nanosized particles extracellularly.
The second barrier to gene delivery is the ability of the polymer to escape from the endosomal-
lysosomal pathway[3,10]. Behr and others introduced the hypothesis of the “proton sponge
effect” and defined polymers having good buffering capacity (as the percentage of amine
groups becoming protonated between pH 7.4 and 5.1) as facilitating endosomal rupture via
osmolysis and thereby inducing efficient gene expression[9,14]. The combination of titratable
amine groups with basic pKa values enables good buffering capacity of a polymer and enhances
DNA binding capability. As a result, gene transfection efficiency increases by incorporating
different amine groups into polymer structures. Our previously synthesized poly(amido
ethylenimine)s containing different amine groups have demonstrated significant higher
transfection efficiencies than bPEI 25kDa in a variety of cell lines[15,16]. Poly(amido amine)
s (PAAs) containing different amine groups showed high buffering capacities and similar or
higher transfection efficiency than bPEI 25kDa in COS-7 cells[17].
To efficiently induce gene expression with low cytotoxicity, polymeric vectors should not only
have superior DNA binding capability and buffering capacity, but also be able to be degraded
into small and non-toxic molecules[4]. To achieve this goal of degradability, the use of disulfide
bonds has received more attention in the design of “bioreducible” polymers[18,19]. Polymers
with disulfide bonds can form stable complexes with DNA in the extracellular oxidative
environment, while readily release DNA intracellulary via the cleavage of the disulfide bonds
by glutathione and other small redox molecules with free thiol groups (5 – 10 mM) through
the efficient disulfide-thiol exchange reaction[20,21]. As a result, gene expression is enhanced
and cytotoxicity is significantly reduced. Previously, improved gene transfection efficiency
and decreased cytotoxicity have been observed when using low molecular weight PEI with
disulfide bonds[22,23]. Recently, PAAs containing disulfide bonds have been demonstrated
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to have higher transfection efficiency and lower cytotoxicity than the counterpart PAAs without
disulfide linkages[24].
To explore the studies of (1) side chain length and (2) main chain spacer on polymeric DNA
binding capability, buffering capacity, protonation degree and basicity, biodegradability and
gene transfection, we synthesized a family of biodegradable poly(disulfide amine)s as
polymeric gene vectors. These poly(disulfide amine)s are synthesized with defined structures:
two pendant primary amine groups at the side chains, two tertiary amine groups and one
disulfide bond in the backbond in each repeating unit and different lengths of oligomethylene
spacers [–(CH2)n–, n = 2-4] in the main and side chains. The characterization of the polymers
includes the measurement of buffering capacity and particle size, DNA condensation and
releasing ability, in vitro transfection efficiency, cytotoxicity and fluorescence-labeled cellular
uptake. We hypothesized that chemical structures in polymer design may play important roles
in gene transfection efficiency and cytotoxicity.
2. Materials and methods
2.1. Materials
All chemicals: spermine (SP, Sigma, St. Louis, MO), N,N′-bis(3-aminopropyl)-1,3-
propanediamine (APPD, Sigma-Aldrich, St. Louis, MO), N,N′-bis(3-aminopropyl)-
ethylenediamine (APED, Acros Organics, Fair Lawn, NJ), N,N′-bis(2-aminoethyl)-1,3-
propanediamine (AEPD, Sigma-Aldrich, St. Louis, MO), triethylenetetramine (TETA, Sigma-
Fluka, St. Louis, MO), N,N′-cystaminebisacrylamide (CBA, PolySciences, Warrington, PA),
branced polyethylenimine (bPEI, Mw=25kDa, Sigma, St. Louis, MO), ethylenediamine (EDA,
Sigma-Aldrich, St. Louis, MO), 2-acetyldimedone (Dde-OH, EMD Chemicals, Inc.
Gibbstown, NJ), hydroxylamine hydrochloride (NH2OH·HCl, Sigma-Aldrich, St. Louis, MO),
imidazole (Sigma-Aldrich, St. Louis, MO), N-methyl-2-pyrrolidinone (NMP, Sigma-Aldrich,
St. Louis, MO), N,N-dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO), 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, Sigma, St. Louis, MO),
dimethyl sulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO), dithiothreitol (DTT, Sigma-
Aldrich, St. Louis, MO), and SYBR® Safe DNA gel stain (10,000×concentrate in DMSO,
Invitrogn, Carlsbad, CA) were purchased in the highest purity and used without further
purification. The plasmid pCMV-Luc, containing a firefly luciferase reporter gene, was
amplified in E.coli DH5α and purified by standard Maxiprep kit (Invitrogen, Carlsbad, CA).
Dulbecco's Modified Eagle's medium (DMEM), penicillin-streptomycin (P/S), fetal bovine
serum (FBS), trypsin-like enzyme (TrypLE Express) and Dulbecco's phosphate buffered saline
(PBS) were all purchased from Invitrogen-Gibco (Carlsbad, CA). Luciferase assay system with
reporter lysis buffer was purchased from Promega (Madison, WI). The BCATM protein assay
system was purchased from Thermo Scientific (Rockford, IL). YOYO-1 iodide (1 mM solution
in DMSO) was purchased from Molecular Probes (Eugene, OR). Hela cells (human cervical
cancer cell line) and C2C12 (mouse myoblast cell line) were purchased from the American
Type Culture Collection (ATCC) and cultured according to recommended protocols.
2.2. Polymer synthesis
The synthesis of five novel poly(disulfide amine)s was shown in Scheme 1. The synthetic route
of poly(cystaminebisacrylamide-spermine) [poly(CBA-SP);] is described here as the
representative procedure. Briefly, SP (0.202g, 1 mmol) and Dde-OH (0.419 g, 2.3 mmol) were
dissolved in 1 mL MeOH, stirring at room temperature for 24 h to let Dde group specifically
protect primary amine groups in spermine. The next day, CBA (0.260g, 1 mmol) was added
into above system in 1.5 mL of MeOH/diH2O (9/1 v/v). Polymerization was conducted at 60°
C in the dark under nitrogen atmosphere for 3-4 days. Then, 10% mol excess EDA was added
to consume any unreacted acrylamide groups, stirring at 60°C for at least additional 2 h. The
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product was precipitated in 40 mL anhydrous diethyl ether to get the intermediate polymer
poly(CBA-SP-Dde). The Dde groups were removed in the deprotection mixture of
NH2OH·HCl/Imidazole/NMP/DMF, stirring at room temperature for 4 h. The deprotection
mixture was prepared as follows: 1.25 g (1.80 mmol) of NH2OH·HCl and 0.918 g (1.35 mmol)
of imidazole were suspended in 5 mL of NMP. The mixture was sonicated until complete
dissolution. Just before reaction, 5 volume of this solution was diluted with 1 volume of DMF
to make the deprotection mixture[25]. After deprotection, the crude product was purified by
dialysis (MWCO = 1000) against MilliQ water for 24 h, followed by lypholization to obtain
poly(CBA-SP) as solid gel. poly(cystaminebisacrylamide-bis(3-aminopropyl)-1,3-
propanediamine) [poly(CBA-APPD);], poly(cyxtaminebisacrylamide-bis(3-aminopropyl)-
ethylenediamine) [ploy(CBA-APED);], poly(cystaminebisacrylamide-bis(2-aminoethyl)-1,3-
propanediamine) [poly(CBA-AEPD);] and poly(cystaminebisacrylamide-
triethylenetetramine) [poly(CBA-TETA);] were synthesized in the same way. These poly
(disulfide amine)s were then analyzed by 1H NMR (400 MHz, D2O, δ, ppm) and the data were
listed as below:
Poly(CBA-SP): δ = 3.37 (CONHCH2CH2SS, 4H), 2.87 (CONHCH2CH2SS, 4H), 2.77
(NCH2CH2CH2NH2, 4H), 2.70 (NHCOCH2CH2N, 4H), 2.53 (NCH2CH2CH2NH2, 4H), 2.47
(NCH2CH2CH2CH2N, 4H), 2.34 (NHCOCH2CH2N, 4H), 1.75 (NCH2CH2CH2NH2, 4H),
1.35 (NCH2CH2CH2CH2N, 4H).
Poly(CBA-APPD): δ = 3.36 (CONHCH2CH2SS, 4H), 2.86 (CONHCH2CH2SS, 4H), 2.71
(NHCOCH2CH2N, 4H; NCH2CH2CH2NH2, 4H), 2.46 (NCH2CH2CH2N, 4H), 2.36
(NCH2CH2CH2NH2, 4H), 2.30 (NHCOCH2CH2N, 4H), 1.70 (NCH2CH2CH2NH2, 4H), 1.53
(NCH2CH2CH2N, 2H).
Poly(CBA-APED): δ = 3.38 (CONHCH2CH2SS, 4H), 2.86 (CONHCH2CH2SS, 4H), 2.70
(NHCOCH2CH2N, 4H; NCH2CH2CH2NH2, 4H), 2.49 (NCH2CH2CH2NH2, 4H;
NCH2CH2N, 4H), 2.30 (NHCOCH2CH2N, 2H), 1.50 (NCH2CH2CH2NH2, 4H).
Poly(CBA-AEPD): δ = 3.37 (CONHCH2CH2SS, 4H), 2.94 (CONHCH2CH2SS, 4H), 2.82
(NCH2CH2NH2, 4H), 2.70 (NHCOCH2CH2N, 4H), 2.60 (NCH2CH2NH2, 4H), 2.44
(NCH2CH2CH2N, 4H), 2.30 (NHCOCH2CH2N, 4H), 1.48 (NCH2CH2CH2N, 2H).
Poly(CBA-TETA): δ = 3.38 (CONHCH2CH2SS, 4H), 2.93 (CONHCH2CH2SS, 4H), 2.83
(NCH2CH2NH2, 4H), 2.69 (NHCOCH2CH2N, 4H), 2.62 (NCH2CH2NH2, 4H), 2.49
(NCH2CH2N, 4H), 2.30 (NHCOCH2CH2N, 4H). The 1H NMR spectra of all poly(disulfide
amine)s are given in the Supporting Information.
2.3. Polymer characterization
The molecular weights of five poly(disulfide amine)s were determined by size exclusion
chromatography (SEC) on an AKTA FPLC system (Amersham Biosciences, Piscataway, NJ)
equipped with a superose 12 column, and UV and refractive index detectors, eluted with Tris
buffer (20 mM, pH 7.4) at a rate of 0.5 mL/min. The molecular weights and polydispersity
index (PDI =Mw/Mn) were calibrated with standard poly[N-(2-hydroxyproyl)
methacrylamide;] (pHPMA). The FPLC spectra data of polymers are given in the Supporting
Information.
2.4. Acid-base titration
The buffering capacity of poly(disulfide amine)s was determined by acid-base titration. An
amount equal to 5 mmol of amine groups of poly(disulfide amine)s was dissolved in 10 mL of
0.1 M NaCl solution. The pH of polymer solutions was initially set to pH 11.0 by 0.1 M NaOH
and titrated to pH 3.0 by using 0.01 M HCl. bPEI 25kDa and 0.1 M NaCl solutions were titrated
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in the same way as controls. The pH of the solutions was measured after each addition by a
pH meter (Corning 340, Mettler-Toledo, Inc, Columbus, OH). Buffering capacity is defined
as the percentage of amine groups that become protonated from pH 7.4 to 5.1 and calculated
using the following equation[11]:
Here ΔVHCl is the volume of HCl solution (0.01 M) which brought the pH value of polymer
solutions from 7.4 to 5.1, and N mol (5 mmol) is the total moles of protonable amine groups
in poly(disulfide amine)s and bPEI. The relationship between pH and protonation degree of
polymers (α) is determined from the obtained titration curve. Further, the apparent pKa of
polymers was plotted against 1-α, while pKa = pH + log [α/(1-α);][26-28].
2.5. Dynamic light scattering (DLS)
The size of polymer/DNA polyplexes was measured using a dynamic light scattering detector
(BI-200SM system, Brookhaven Instruments, Holtsville, NY) equipped with a 5 mW helium
neon incident laser beam at 633 nm output wavelength. Polyplexes were prepared at weight
ratios (w/w) of 1, 5, 10, 20 and 30 by mixing poly(disulfide amine)s and bPEI 25 kDa with 1
μg plasmid DNA in diH2O, followed by vortexing for 5 s and incubating at room temperature
for 30 min. The polyplexes were then diluted in 2 mL of dust-free diH2O. Measurements were
made at 25°C at a scattering angle of 90°. Each measurement was repeated triplicate. The
particle sizes were expressed as effective diameters and mean values ± standard deviations.
2.6. Gel electrophoresis assay
Agarose gel (1%, w/v) containing 0.5 μg/mL SYBR® Safe DNA gel stain was prepared in TAE
(Tris-Acetate-EDTA) buffer. Poly(disulfide amine)s/DNA complexes (0.5 μg DNA) were
prepared in 20 μl of 20 mM HEPES buffer (pH 7.4) at w/w ratios of 0.1, 0.2, 0.5, 1, 2, 5, 10,
20 and 30, followed by vortexing for 5 s and incubating at room temperature for 30 min. bPEI
25kDa/DNA complexes (w/w 1:1) was prepared for comparison. The samples were mixed with
4 μl of 6 × loading dye and the mixtures were loaded onto an agarose gel. The gel was run at
100 V for 30 min and the location of DNA bands was visualized by a UV illuminator using a
Gel Documentation Systems (Bio-Rad, Hercules, CA). The DNA release from polyplexes was
evaluated by incubating polyplexes with 10 mM DTT at 37°C for 1 h. The samples were
analyzed by gel electrophoresis as same manners.
2.7. In vitro transfection
Poly(disulfide amine)s mediated gene transfection was evaluated on Hela and C2C12 cell lines
by using luciferase reporter gene (pCMV-Luc, 1.0 μg/mL) in the absence of serum. Cells were
maintained in DMEM containing 10% FBS, streptomycin (100 μg/mL) and penicillin (100
units/mL) at 37°C with 5% CO2 humidified atmosphere. 24 h prior to transfection, cells were
seeded in 24-well plates at an initial density of 4.5 × 104 cells/well. Poly(disulfide amine)s/
DNA complexes were prepared in 20 mM HEPES buffer (pH 7.4) 30 min before transfection
at w/w ratio of 1, 5, 10, 20 and 30. bPEI (25 kDa)/DNA complexes (w/w 0.6:1) transfected
cells and non-treated cells were used as positive and negative controls. At the time of
transfection, the medium in each well was replaced with fresh serum-free medium. Polyplexes
were added into each well and incubated with the cells at 37°C for 4 h. Then the serum-free
medium was replaced with 500 μL of fresh complete medium. With additional 44 h incubation,
cells were washed with pre-warmed PBS, treated with 100 μL cell lysis buffer and subjected
to a freezing-thawing cycle. Cellular debris was removed by centrifugation at 16,000 rpm for
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2 min. The luciferase activity in cell lysate (25 μL) was measured using a luciferase assay kit
(100 μL luciferase assay buffer) on a luminometer (Dynex Technologies Inc., Chantilly, VA).
The relative luminescent unit (RLU) of luciferase expression was normalized against protein
concentration in the cell extracts, measured by a BCA protein assay kit. All transfection assays
were carried out in triplicate.
2.8. Cytotoxicity assay
In vitro cytotoxicity of poly(disulfide amine)s was evaluated using MTT assay in C2C12 cells.
Polyplexes were prepared at w/w ratio of 1, 5, 10, 20 and 30 as described above 30 min before
use with bPEI 25kDa as comparison. Cells were incubated with polyplexes in serum-free
medium for 4 h followed by 20 h incubation in complete medium with 10% FBS. MTT solution
in PBS (50 μL, 2 mg/mL) was then added and the cells were further incubated for 2 h. The
medium was removed and 300 μL DMSO was added to each well to dissolve the formazan
crystal formed by viable cells. The optical densities of each well were measured at 570 nm
using a microplate reader (Model 680, Bio-Rad Lab, Hercules, CA) and expressed as a
percentage relative to control cells (untreated cells). All cytotoxicity experiments were
performed in triplicate. The relative cell viability was calculated according to the equation:
([Abs]sample-[Abs]blank)/([Abs]control-[Abs]blank)×100%.
2.9. Cellular uptake assay
The cellular uptake of polyplexes was examined by flow cytometry. Approximately 2 × 105
C2C12 cells were seeded in 12-well plates 24 h prior to study. YOYO-1 iodide tagged pCMV-
Luc (1 molecule of YOYO-1 dye per 20 base pairs of nucleotide) was prepared 30 min before
use. Then polyplexes were prepared by mixing poly(disulfide amine)s with YOYO-1 labeled
plasmid DNA at w/w ratio of 1, 5, 10, 20 and 30 as described above. At the time of transfection,
fluorescence labeled polyplexes (1.0 μg/mL DNA) was incubated with cells at 37°C for 4 h in
serum-free medium. Then medium was removed by aspiration and the cells were washed with
PBS, harvested by trypsin-like enzyme (TrypLE Express) and neutralized with serum
containing medium. After centrifugation at 1500 rpm for 2 min, cells were fixed with 2%
paraformaldehyde in PBS-0.5% BSA solution for 20 min at room temperature, and washed
and resuspended in 0.3 mL ice-cold PBS. Samples were kept in ice and analyzed by a FACScan
analyzer (BD Biosciences, San Jose, CA) at a minimum of 1 × 104 cells using FL1-height
channel for YOYO-1 dye. Non-treated cells are used as control for calibration. Experiments
were performed in duplicate. Data were analyzed by using Windows Multiple Document
Interface software, version 2.9 (WinMDI, Microsoft, Redmond, Washington).
3. Results
3.1. Synthesis of poly(disulfide amine)s
Five biodegradable poly(disulfide amine)s with different length of oligomethylene spacer [–
(CH2)n–] where n = 2-4 in the main chain and the side chain were synthesized in a two-step
process shown in Scheme 1. First, 2-acetyldimedone (Dde-OH) was used to protect primary
amines of five oligoamine monomers (SP, APPD, APED, AEPD, and TETA). Second,
polymerizations were carried out between Dde-protected monomers and disulfide containing
bisacrylamide based on Michael addition. The secondary amines in oligoamine monomers
were converted into tertiary amines in the polymer main chains during polymerization. Pendant
primary amines in polymer side chains were revealed by removing Dde protecting groups in
NH2OH·HCl/Imidazole/NMP/DMF solution. The final polymer structures were confirmed
by 1H NMR to contain one disulfide bond and two tertiary amine groups in the main chain and
two pendant primary amine groups in the side chains in each repeating unit. Poly(CBA-SP),
poly(CBA-APPD) and poly(CBA-APED) have propylene [–(CH2)3–] side chain spacer and
butylene [–(CH2)4–], propylene [–(CH2)3–], and ethylene [–(CH2)2–] main chain spacers,
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respectively. Poly(CBA-AEPD) and poly(CBA-TETA) have shorter ethylene [–(CH2)2–] side
chain spacer and shorter propylene [–(CH2)3–] and ethylene [–(CH2)2–] main chain spacers,
respectively. The disappearance of signal peaks between δ 5 to 7 ppm indicated that the
polymerization was complete and that acrylamide end groups did no longer exist in the final
polymer products. The range of weight average molecular weight (Mw) of poly(disulfide
amine)s was from 3.8 to 6.1 kDa with narrow polydispersities (PDI = 1.15 ∼ 1.33) (Table 1).
3.2. Characterization of poly(disulfide amine)s and polyplexes
Buffering capacity is an important feature for cationic polymers, as set out in the “proton
sponge” hypothesis, by facilitating the endosomal escape of polyplexes to mediate efficient
gene expression[3,9]. Poly(disulfide amine)s exhibited high buffering capacity, as 26-38% of
amine groups become protonated in the endosomal-lysosomal pH range (7.4 to 5.1). This is
higher than the buffering capacity of bPEI 25kDa (22%) and manifests as relatively flatter
slopes in the acid-base titration curve (Figure 1A and Table 1). Poly(CBA-SP) and poly(CBA-
APPD) have higher buffering capacity (38%, 36% respectively) than that of poly(CBA-APED),
poly(CBA-AEPD) and poly(CBA-TETA) (26%, 28%, 28% respectively). The high buffering
capacity of poly(disulfide amine)s may be attributed to the combined effect of the primary and
tertiary amine groups in these polymers.
The protonation degree (α) of cationic polymers at neutral and endosomal acidic pH (from 7.4
to 5.1) is another important factor to determine polymer basicity (protonation ability) and for
successful gene transfection[26]. The α of polymers can be estimated from titration curve in
the pH range of 11 to 3 as shown in α-pH curve (Figure 1B and Table 1). At pH 7.4, the
protonation degrees of five poly(disulfide amine)s and bPEI 25kDa are similar ranging from
52% to 55% due to the ready protonation of primary amine groups in polymer structures under
neutral conditions. At pH 5.1, the protonation degree of poly(disulfide amine)s (71.5% - 76.5%)
are relatively higher than that of bPEI (69%), showing higher degree of tertiary amine groups
have been protonated than bPEI under the endosomal acidic conditions. These results indicated
that poly(disulfide amine)s have relatively higher basicity than bPEI. In addition, poly(CBA-
SP), poly(CBA-APPD), and poly(CBA-APED), have relatively higher protonation degree
(76.5%, 76%, 73%, respectively) than that of poly(CBA-AEPD) and poly(CBA-TETA)
(71.5% and 72%) at pH 5.1.
Due to the primary and tertiary amine groups in structures, poly(disulfide amine)s
demonstrated two steps of protonation from pH 11 to 3. Apparent pKa values in the first and
second protonations were defined as pKa1 (α = 25%) and pKa2 (α = 75%), respectively
[26-28]. From the pKa/1-α curve (Figure 1C and Table 1), pKa1 for poly(disulfide amine)s is
similar from 9.51 to 9.63, which is for the protonation of primary amine groups. In the second
step of protonation, tertiary amine groups will be protonated (pKa2). It is noting that pKa2 of
poly(CBA-SP) and poly(CBA-APPD) (5.85 and 5.76) are relatively higher than that of poly
(CBA-APED), poly(CBA-AEDP) and poly(CBA-TETA) (4.75, 4.89, and 5.05, respectively).
The poly(disulfide amine)s with longer propylene side chain spacer [–(CH2)3–] have higher
basicity than the polymers with shorter enthylene side chain spacer [–(CH2)2–]. Therefore, one
more methylene unit between two amine groups in the side chain and main chain of polymers
may effectively enhance higher buffering capacity and basicity to facilitate the protonation
during endosome-lysosome pathway.
To determine the size distribution of polyplexes with variant w/w ratios, dynamic light
scattering (DLS) was used. As Fig. 2 shows, all poly(disulfide amine)s condensed DNA into
particles as effective diameter below 200 nm at w/w ratio of 5:1. Significant size reduction to
∼150 nm was observed for polyplexes at w/w ratio of 10:1. The particle sizes reduced to ∼100
nm when w/w ratio was 20:1 for polyplexes. The results proved that cationic poly(disulfide
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amine)s can electrostatically condense negatively charged plasmid DNA into stable
nanoparticles which are necessary for efficient cellular uptake.
The formation of poly(disulfide amine)s/DNA polyplexes was also studied by gel retardation
assay. As Fig.3A shows, poly(CBA-SP) and poly(CBA-APPD) completely retard DNA
migration at a w/w ratio of 1:1. Poly(CBA-APED) partially retains DNA migration at a w/w
ratio of 1:1 and completely retains DNA migration at a w/w ratio of 2:1. DNA was completely
retained by poly(CBA-AEPD) and poly(CBA-TETA) at a w/w ratio of 2:1. In the presence of
disulfide reducing agent DTT incubation at 37°C for 1 h, free DNA was released from all of
the poly(disulfide amine)s/DNA polyplexes (Figure 3B). For the comparable non-degradable
polymer bPEI 25kDa, there was no free DNA release from the bPEI polyplexes with DTT
incubation. Agarose gel electrophoresis confirmed that all poly(disulfide amine)s have good
DNA condensing capability at low w/w ratios. A longer side and main chain spacer allows a
higher degree of protonation and thus a higher positive charge density of polymers.
Consequently, the poly(disulfide amine)s with longer side and main chain spacer have a
stronger ability to form stable complexes with DNA extracellularly than the polymers with
shorter side and main chain spacer. In addition, these poly(disulfide amine)s are ready to release
DNA intracellulaly via disulfide bonds cleavage by small redox molecules with free thiol
groups through the efficient disulfide-thiol exchange reactions, thereby mediating efficient
gene transfection.
3.3. In vitro gene transfection
Fig. 4 shows the luciferase expression levels mediated by poly(disulfide amine)s as a function
of polymer/DNA w/w ratios. The goal of this experiment was to evaluate gene transfection
efficiency of the poly(disulfide amine)s in different cell lines. Two model cell lines were chosen
to approximate potential human diseases as targets for polymeric gene therapy. A Hela cancer
cell line was used to evaluate gene transfection efficiency in cells with characteristics of human
cervical carcinoma. A C2C12 myoblast cell line was to evaluate gene transfection efficiency
in cells with characteristics of diseases of human muscle such as muscular dystrophy or
ischemic heart disease. Luciferase expression as mediated by bPEI 25kDa was used as the
control, demonstrating the optimal transfection without cytotoxicity at w/w ratio of 0.6:1 (N/
P ∼ 5:1). Luciferase expression mediated by the poly(disulfide amine)s was much higher than
that mediated by bPEI 25kDa from a w/w ratio of 5:1 to 30:1. In Hela cells, poly(CBA-APED)
showed the highest transfection efficiency, up to 351-fold higher than that of bPEI 25kDa. In
C2C12 cells, the highest luciferase expression was mediated by poly(CBA-SP), which was
146-fold higher than that of bPEI. It seems that transfection efficiency is oligomethylene length
dependent for poly(disulfide amine)s. The poly(CBA-SP), poly(CBA-APPD), and ploy(CBA-
APED), with the longer propylene [–(CH2)3–] side chain spacer, demonstrated higher
transfection efficacy than their counterparts: poly(CBA-AEPD) and poly(CBA-TETA), which
have shorter ethylene [–(CH2)2–] side chain spacer. Although poly(CBA-SP), poly(CBA-
APPD), poly(CBA-APED) with different main chain spacer of –(CH2)4–, –(CH2)3–, –
(CH2)2– demonstrated similar transfection efficiency in the two cell lines, the oligomethylene
length of main chain spacer also had influence on transfection efficiency. With the same short
ethylene [–(CH2)2–] side spacer, poly(CBA-AEPD) with longer propylene main chain spacer
[–(CH2)3–] demonstrated higher luciferase expression than poly(CBA-TETA) with shorter
ethylene main chain spacer[–(CH2)2–], which may due to higher level of buffering capacity,
protonation degree of tertiary amine groups and basicity of poly(CBA-AEPD) caused by longer
main chain spacer. The order of gene transfection efficiency among the poly(disulfide amine)
s is poly(CBA-SP) ≈ poly(CBA-APPD) ≈ poly(CBA-APED) > poly(CBA-AEPD) > poly
(CBA-TETA) > bPEI 25kDa. The results indicate that the chemical structures of the polymers
influence their biophysical properties. The combination of primary and tertiary amines gives
these polymers good DNA binding capability and buffering capacity, while the disulfide bonds
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in the structures of the polymers enable the release of free DNA efficiently from the polyplexes
to induce efficient gene expression. Additionally, the longer side and main chain spacer gives
these polymers higher degree of protonation, basicity and charge density so that the enhanced
ability of transfecting cells and higher levels of gene expression are observed in poly(disulfide
amine)s.
3.4. Cytotoxicity
The in vitro cytotoxicity of the poly(disulfide amine)s was evaluated by MTT assay in C2C12
cells as a function of polymer/DNA w/w ratios (Figure 5). Results showed that all the poly
(disulfide amine)s have overall lower cytotoxicity than bPEI 25kDa. Cells incubated with poly
(CBA-SP), poly(CBA-APPD) and poly(CBA-APED) remained ∼ 80% and ∼ 50% viable at
w/w ratio of 10:1 and 30:1. Poly(CBA-AEPD) and poly(CBA-TETA) exhibited no toxicity in
the cells, which remained ∼ 100% viabile at a w/w ratio of 30:1. In contrast, only 12% of the
cells incubated with bPEI 25kDa remained viable at a w/w ratio of 30:1. The results were
similar with the Hela cells (data not shown). MTT assay demonstrated that poly(disulfide
amine)s have a broad range of polymer/DNA w/w ratios where high level of transfection
efficiency and low level of cytotoxicity are manifest.
3.5. Transfection mechanism study of poly(disulfide amine)s
Using YOYO-1 iodide interclated pCMV-Luc, the cellular uptake of the polyplexes was
estimated by flow cytometry in C2C12 cells as a function of the poly(disulfide amine)s/DNA
w/w ratios (Figure 6). The results showed that the uptake of polyplexes increased with the
increasing of w/w ratios from 1:1 to 30:1, with the fluorescent signals shifting to the stronger
histogram area (M1 region). The proportion of cells taking up polyplexes (% cell count in R2
region) by poly(CBA-SP), poly(CBA-APPD) and poly(CBA-APED) was ∼ 99% at all w/w
ratios (data not shown). At w/w ratio of 1:1, poly(CBA-AEPD) and poly(CBA-TETA) induced
77% and 71% cellular uptake. At a w/w ratio of 5 and above, poly(CBA-AEPD) and poly
(CBA-TETA) increased cellular uptake to ∼ 99%. These results agreed with previous results
that poly(disulfide amine)s can mediate high level of gene transfection in cells. Also, poly
(CBA-SP), poly(CBA-APPD) and poly(CBA-APED), which contain the propylene side
spacers [–(CH2)3–], can induce higher levels of cellular uptake and transfection efficiency than
poly(CBA-AEPD) and poly(CBA-TETA), which contain the ethylene side spacers [–
(CH2)2–]. The longer propylene main chain spacer [–(CH2)3–] also enable poly(CBA-AEPD)
having relatively higher cellular uptake than poly(CBA-TETA) with shorter ethylene main
chain spacer [–(CH2)2–].
4. Discussion
Gene therapy is defined as the delivery of genetic information to specific cells to direct the
synthesis of specific proteins to treat a disease[29]. A key component of any gene therapy is
the delivery vehicle. Through September 2008, 1472 clinical trials of gene therapy have been
conducted worldwide (www.wiley.co.uk/genetherapy/clinical). Among these clinical trials,
approximately 70% used viral vectors while less than 30% used non-viral methods to delivery
DNA. While viral vectors allow for the potential for high gene transfection efficiency to cells,
they suffer from a number of significant limitations including: 1) the potential for induced
mutagenesis; 2) limited nucleic acid loading capacity; and 3) immunogenicity with repeat
administration[2]. All of these factors limit the use of viral vectors in clinical applications. For
these reasons, cationic polymers for gene delivery have been developed to overcome the
inherent limitations of viral vectors. In general, synthetic polymeric vectors have previously
had lower gene transfection efficiency than viruses but greater safety, stability, and ease of
production and modification than viral vectors[10,29].
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In this study, a series of biodegradable poly(disulfide amine)s were synthesized in order to
evaluate the effect of the structure-function relationship of this class of polymers on gene
delivery. To develop polymers with superior DNA binding ability, basicity, protonation ability
and buffering capacity, we introduced primary and tertiary amine groups into the polymer
structures. To give the polymers the property of biodegradability, disulfide bonds were
incorporated into the polymer backbones. To determine whether different length of
oligomethylene spacers affect the transfection capacity of polymeric carriers, butylene [–
(CH2)4–], propylene [–(CH2)3–], and ethylene [–(CH2)2–] spacers were introduced into the
polymer main chain and side chains. The results confirmed our hypothesis that the functional
groups within the polymer structures govern the DNA binding ability, protonation ability,
basicity, buffering capacity and environmental biodegradability of the polymers, thereby
improving gene transfection efficiency and lowering cytotoxicity.
DNA binding capability is an important feature of cationic polymers in determining capacity
for gene delivery[30,31]. A high positive charge density will condense DNA into nanosized
particles and allow efficient cellular uptake through endocytosis. Since cytoplasm contains
nucleases, cationic polymers with strong DNA binding ability will prevent nucleic acid
degradation and inactivation[32]. Once internalized, the polyplexes traffic through the
endosomal-lysosomal sorting pathway. Polymers that have a buffering capacity between pH
7.4 and 5.1 are able to mediate endosomal-lysosomal escape based on the “proton sponge
effect”[9,14]. This “proton spong effect” hypothesis was recently proved by Sonawane et al,
showing that polymers with titratable amine groups such as PEI can increase the influx of
H+ and the counterion Cl− into the endosome, resulting in swelling and rupture of the
endosomal membrane by increasing osmotic pressure and mechanical perturbation[33]. Escape
of the polyplexes is another major barrier and a requirement for delivery of DNA into the
nucleus for efficient gene transfection. Previously, Wong et al. synthesized a series of pH
sensitive polymers as gene carriers[34]. Their results showed that the polymers containing
primary amine pendant groups have superior DNA binding and size-condensing ability and
therefore superior gene transfection efficiency compared to the polymers containing only
secondary and tertiary amine pendant groups. Zugates et al. used different amine groups to
modify poly(β-amine ester)[12,13]. They found that the modified poly(β-amine ester) with
primary amine end groups has stronger DNA binding affinity and forms smaller nanoparticles
with DNA and induces higher gene transfection efficiency than the counterpart poly(β-amine
ester) with regular alcohol end groups. Lin et al. synthesized a series of poly(amido amine)s
(PAAs) and found out that the polymers with primary, secondary and tertiary amine groups
showed higher buffering capacity and gene transfection efficiencies than bPEI 25kDa[17]. In
our study, the results of gel electrophoresis showed that poly(disulfide amine)s have strong
DNA binding capability such that they can completely condense DNA into stable complexes
at very low w/w ratios. The formed nanoparticles have an effective diameter below 200 nm as
measured by dynamic light scattering. Based on the results of acid-base titration, all poly
(disulfide amine)s have superior buffering capacity and protonation degree as compared to
bPEI 25kDa. As a result, our poly(disulfide amine)s induced efficient cellular uptake of
polyplexes and much higher luciferase expression than bPEI 25kDa in two model cell lines.
Disulfide bonds are another functional group used to solve the problem of the cytotoxicity of
cationic polymers[24,35]. The disulfide bonds can be cleaved in the cytoplasm by lots of small
redox molecules with free thiol groups, including reduced glutathione, cysteine,
cysteinylglycine, and homocysteine[21]. Since the concentration of these reducing agents is
2-20 μM in plasma, which is much lower than that in the cytoplasma (∼10 mM), the disulfide
bonds are relatively stable in the extracellular environment, but readily be degradable in the
intracellular environment through the efficient disulfide-thiol exchange reaction[20,21]. This
feature gives the disulfide bond-containing polymers the ability to form stable complexes with
DNA extracellulary and release free genes intracellularly to induce efficient gene expression,
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while at the same time, to reduce cytotoxicity through polymer degradation. Oupicky et al.
showed the disulfide-containing PLL have a much higher gene transfection efficiency than the
counterpart non-degradable PLL[36]. Lin synthesized a series of bioreducible PAAs
copolymers and found out that the polymers having higher numbers of disulfide bonds induced
much higher transfection efficiency and lower cytotoxicity than the analogous polymers
without disulfide bonds[24,37]. Our previously synthesized poly(amido ethylenimine)s also
mediated much higher transfection efficiency and lower cytotoxicity than bPEI 25kDa in
different cell lines[15]. In this study, in the presence of DTT incubation, free DNA was released
from poly(disulfide amine)s/DNA complexes in the gel electrophoresis. The poly(disulfide
amine)s showed higher transfection efficiency and much lower cytotoxicity than bPEI 25kDa
based on luciferase assay and MTT assay results.
The poly(disulfide amine)s with propylene [–(CH2)3–] side chains, such as poly(CBA-SP),
poly(CBA-APPD) and poly(CBA-APED), showed higher DNA binding capability, buffering
capacity and gene transfection efficiency than the counterpart polymers with ethylene [–
(CH2)2–] side chains, e.g. poly(CBA-AEPD) and poly(CBA-TETA). The finding is that the
relatively longer and more hydrophobic and flexible side groups will give these polymers
higher transfection efficiency. Lin et al. synthesized a series of PAAs with different pendant
functional groups, in which the polymers with longer alkyl chain have better gene transfection
than the ones with shorter alkyl chains: pAPOL > pABOL > pMOPA[11]. Wong et al. found
out that the polymers with longer carbonyl pendant groups had greater stability, DNA binding
ability and gene transfection efficiency[34]. It is hypothesized that the longer hydrophobic
residues promote interactions between the polyplexes and the target cell membrane, which
results in efficient cellular uptake and higher gene transfection efficiency. In addition, the
hydrophobic residues may increase the stability of the polyplexes, suggesting that alkylation
may drive the polyplexes to a more thermodynamically favorable conformational arrangement
so that DNA is prevented from being dissociated readily, even in the presence of competing
polyanion[31,34,38]. As a result, the polymers with longer and hydrophobic side chains have
the capacity for enhanced gene transfection. The longer oligomethylene spacer in main chain
also benefits polymer gene transfection due to the enhanced polymer backbone flexibility,
which may help polymer to form a more stable confirmation with DNA. Jones et al. observed
that the polymer with the more flexible backbone of two tertiary amine and ethylene groups
(pMBA-DMEDA) has better DNA binding ability and gene transfection than the polymers
with only one tertiary amine group and rigid piperazine rings (pMBA-MMA and pMBA-2MP)
[39].
The oligomethylene length in main chain and side chain may also influence the protonation
degree, basicity, and buffering capacity of polymers. Primary amines of the poly(disulfide
amine)s have similar pKa1 (9.51 - 9.63) and are almost completely protonated at physiological
pH. It seems the oligomethylene spacer has little influence on basicity of primary amine groups.
However, the protonation degree of nitrogens in tertiary amines in polymer main chain will be
dependent on both the side chain and main chain oligomethylene length. Poly(CBA-SP) and
poly(CBA-APPD) have the longest oligomethylene units in side chain and main chain and the
highest buffering capacity, protonation degree and basicity of tertiary amines. Poly(CBA-
APED) has propylene unit [–(CH2)3–] in side chain but ethylene unit [–(CH2)2–] in main chain,
it has lower buffering capacity and protonation degree than the above two polymers. And poly
(CBA-AEPD) and poly(CBA-TETA) have the shortest oligomethylene units in their side and
main chain and the lowest buffering capacity and protonation degree. When two amine groups
are separated by ethylene spacer [–(CH2)2–] in main chain and side chain, the strong
electrostatic repulsion between two charged amino nitrogen atoms may decrease the
protonation degree of tertiary amines in polymer main chain. The longer side chain and main
chain spacer will reduce the repulsion between the charged amine groups and therefore increase
the protonation degree and basicity of tertiary amine groups[26]. Taken together, these results
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show that the structure properties of the polymers influence their nucleic acid binding
capability, charge-density, buffering capacity and gene transfection efficiency. Further
investigation will be needed to fully understand the underlying mechanisms regarding how
oligomethylene spacers in polymer side chain and main chain influence polymeric gene
transfection efficiency.
Finally, another important feature of poly(disulfide amine)s is their cytotoxicity profile.
Although poly(CBA-AEPD) and poly(CBA-TETA) have lower gene transfection efficiency,
they have less cytotoxicity than poly(CBA-SP), poly(CBA-APPD) and poly(CBA-APED). As
discussed above, the reason may be that the longer and more hydrophobic residues have more
influence on the polyplexes-cell membrane interaction[34,38,40]. As a result, these
hydrophobic residues may cause more cell membrane disruption and cytotoxicity. The
important point, however, is that all the poly(disulfide amine)s are significant less cytotoxic
than bPEI 25kDa. This low toxicity profile suggests that the biodegradable poly(disulfide
amine)s will be a feasible, safe and promising gene vectors for future studies in gene delivery.
5. Conclusion
We have synthesized and evaluated a family of bioreducible poly(disulfide amine)s as
polymeric gene vectors. The incorporation of multiple functional groups, such as amine groups
and disulfide bonds, give these cationic polymers good DNA condensation ability, protonation
ability, charge density, buffering capacity and intracellular biodegradability. The longer, more
hydrophobic oligomethylene side chains and more flexible backbones of these polymers with
[–(CH2)n–, where n = 2-4] increase gene transfection efficiency which may due to the enhanced
buffering capacity, protonation degree of tertiary amine groups, and basicity and charge density
of polymers. The results of these analyses: (1) identify a series of polymeric vectors with higher
transfection efficiency and lower cytotoxicity than bPEI 25kDa; (2) reveal the structure-
function relationships between different lengths of polymer backbones and side chains and the
gene transfection efficiency of the polymers; and (3) describe a polymer family that is a safe
and efficient vector system for gene delivery.
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Figure 1.
Buffering capacity and protonation behavior of poly(disulfide amine)s. (A) Titration curves of
poly(disulfide amine)s. Polymers with 5 mmol amino nitrogen atoms were dissolved in 10 mL
of 1.0 M NaCl. Solutions were initially set to pH 11.0 by 0.1 M NaOH and then titrated by
0.01 M HCl to pH 3.0. As a reference, the titration curves of bPEI (25 kDa) and 0.1 M NaCl
were also presented. (B) Protonation degree (α) – pH curves of poly(disulfide amine)s in the
pH range of 11 to 3. (C) Apparent pKa – (1-α) curves of poly(disulfide amine)s.
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Figure 2.
Average particle sizes of poly(disulfide amine)s/DNA polyplexes at w/w ratios of 1:1, 5:1,
10:1, 20:1 and 30:1. bPEI (25 kDa)/DNA polyplexes were measured at the same w/w ratios
for comparison. The experiments were repeated three times and the data were represented as
mean value ± standard deviations.
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Figure 3.
Gel retardation assay of poly(disulfide amine)s/DNA polyplexes at varying w/w ratios at the
conditions of (A) without and (B) with DTT incubation (10.0 mM, 37°C, 1 h). Lane assignments
correspond to polymer/DNA w/w ratios and represented as: lane 1 (0:1, plasmid DNA); lane
2 (bPEI (25kDa)/DNA 1:1); lane 3 (0.1:1); lane 4 (0.2:1); lane 5 (0.5:1); lane 6 (1:1); lane 7
(2:1); lane 8 (5:1); lane 9 (10:1); lane 10 (20:1); lane 11 (30:1).
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Figure 4.
Transfection efficiency of poly(disulfide amine)s/pCMV-Luc polyplexes at varying w/w ratios
in two different cell lines. (A) HeLa cells: human cervical cancer cell line; (B) C2C12 cells:
mouse myoblast cell line. Control: non-treated cells. The transfection efficiency of bPEI
(25kDa)/DNA at optimal w/w ratio of 0.6:1 was measured for comparison. The w/w ratios of
poly(disulfide amine)s/DNA were 1:1, 5:1, 10:1, 20:1, and 30:1. Transfection experiments
were repeated three times and the results were expressed as the relative luminescent unit (RLU)
of luciferase reporter gene expression normalized by the total cell protein content in each well
as mean values ± standard deviations.
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Figure 5.
Relative cell viabilities of poly(disulfide amine)s/DNA polyplexes were measured as a function
of w/w ratios in C2C12 cells. The polymer/DNA w/w ratios were set as 1:1, 5:1, 10:1, 20:1
and 30:1. The MTT assay of bPEI (25kDa)/DNA at the same w/w ratio was measured for
comparison. Cytotoxicity was repeated three times and the data were represented as mean
values ± standard deviations.
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Figure 6.
The cellular uptake of poly(disulfide amine)s/DNA polyplexes in C2C12 cells. Fluorescence
histogram intensity correspond to polymer/DNA w/w ratios and represented as: closed grey
peak (control, untreated cells); red line (1:1); green line (5:1); blue line (10:1); purple line
(20:1); light blue line (30:1); M1 region (M1 gated fluorescent intensity).
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Scheme 1.
Synthesis of poly(disulfide amine)s using oligoamines and bisacryamide monomers ((poly
(CBA-SP), poly(CBA-APPD), poly(CBA-APED), poly(CBA-AEPD) and poly(CBA-
TETA)). The synthetic route of poly(CBA-SP) is shown as a representative procedure.
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